https://law.temple.edu/contact/rachel-rebouche/
Dean Rebouché has served as a co-investigator on two grant-funded research projects related to reproductive health, one housed at the Emory University Rollins School of Public Health and another funded by the World Health Organization.
https://www.templehealth.org/doctors/rebecca-armbruster
Training Residency, Internal Medicine, Philadelphia College of Osteopathic Medicine, Philadelphia, PA
https://owlsports.com/sports/womens-volleyball/roster/2009
The official 2009 Women's Volleyball Roster for the Temple University Owls
https://templetv.net/shows/high-flying-owls/high-flying-owls-episode-13/
On this episode of High Flying Owls, Professor Dwight Carey talks about jewelry–specifically how jewelry can be a lifesaver–with Temple alumae, Yasmine Mustafa and Desiree Cavalancia.
https://digitalcampus-swankmp-net.libproxy.temple.edu/temple280061/play/d7aee2d8d3b8f0e5
We would like to show you a description here but the site won’t allow us.
https://physicianresources.templehealth.org/participant/ajay-rao-md-mmsc-facp
Ajay Rao, MD, MMSc, FACP Chief, Section of Endocrinology, Diabetes and Metabolism Associate Professor, Medicine Associate Professor, Center for Metabolic Disease Research
https://www.temple.bncollege.com/?graphicId=x&categoryId=40493&parentCatId=40363&topCatId=40351&imageId=1811275?graphicId=x&categoryId=40493&parentCatId=40363&topCatId=40351&imageId=1811275
www.temple.bncollege.com
https://digital.library.temple.edu/digital/api/collection/p245801coll10/id/237450/download
To experience full interactivity, please enable Javascript in your browser.
https://owlsports.com/sports/womens-volleyball/roster/gem-grimshaw/11310
Gem Grimshaw (5) OH/RS - 2021: 2021-22 AAC All-Academic Team. . . AAC Weekly Honor Roll (Sept. 6). . . Arthur Ashe, Jr. Sports Scholarship Award Second Team....
https://www.templehealth.org/services/lung/research-clinical-trials/study-evaluating-safety-and-efficacy-of-ap01-in-participants-with-progressive-pulmonary-fibrosis
A randomized, double-blind, placebo-controlled clinical study to evaluate the safety and efficacy of 2 doses of AP01 versus placebo on top of standard of care in participants with PPF over 52 weeks.